{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:39:53Z","timestamp":1790948393912,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejpn.2025.09.001","type":"journal-article","created":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:26:12Z","timestamp":1757255172000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The ins and outs of glycopyrronium treatment for paediatric drooling: exploring the treatment journey using real-world data"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0561-4768","authenticated-orcid":false,"given":"Lynn B.","family":"Orri\u00ebns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9456-3450","authenticated-orcid":false,"given":"Karen","family":"van Hulst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce M.","family":"Geelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.A.","family":"van den Hoogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne T.M.","family":"Dittrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7860-7791","authenticated-orcid":false,"given":"Mich\u00e8l A.A.P.","family":"Willemsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6657-941X","authenticated-orcid":false,"given":"Corrie E.","family":"Erasmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpn.2025.09.001_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tripleo.2005.08.018","article-title":"Drooling of saliva: a review of the etiology and management options","volume":"101","author":"Meningaud","year":"2006","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.ejpn.2025.09.001_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.infbeh.2018.01.004","article-title":"Development of the drooling infants and preschoolers scale (DRIPS) and reference charts for monitoring saliva control in children aged 0-4 years","volume":"50","author":"van Hulst","year":"2018","journal-title":"Infant Behav. Dev."},{"issue":"6","key":"10.1016\/j.ejpn.2025.09.001_bib3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1469-8749.2008.03243.x","article-title":"Drooling in cerebral palsy: hypersalivation or dysfunctional oral motor control?","volume":"51","author":"Erasmus","year":"2009","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2025.09.001_bib4","unstructured":"L. Glader, C. Delsing, A. Hughes, J. Parr, L. Pennington, D. Reddihough, et al., AACPDM care pathway for sialorrhea in cerebral palsy (2017) [updated June 2018]. Available from: http:\/\/www.aacpdm.org\/publications\/care-pathways\/sialorrhea."},{"key":"10.1016\/j.ejpn.2025.09.001_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/dmcn.14888","article-title":"Posterior drooling in children with cerebral palsy and other neurodevelopmental disorders","author":"Delsing","year":"2021","journal-title":"Dev. Med. Child Neurol."},{"issue":"2","key":"10.1016\/j.ejpn.2025.09.001_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1017\/S0012162206000235","article-title":"Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care","volume":"48","author":"van der Burg","year":"2006","journal-title":"Dev. Med. Child Neurol."},{"issue":"2","key":"10.1016\/j.ejpn.2025.09.001_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.mrr.0000194395.64396.f1","article-title":"Drooling in children with cerebral palsy: a qualitative method to evaluate parental perceptions of its impact on daily life, social interaction, and self-esteem","volume":"29","author":"van der Burg","year":"2006","journal-title":"Int. J. Rehabil. Res."},{"issue":"1","key":"10.1016\/j.ejpn.2025.09.001_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00431-005-1759-z","article-title":"Social interaction and self-esteem of children with cerebral palsy after treatment for severe drooling","volume":"165","author":"van der Burg","year":"2006","journal-title":"Eur. J. Pediatr."},{"issue":"3","key":"10.1016\/j.ejpn.2025.09.001_bib9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/dmcn.14391","article-title":"Changes in severity and impact of drooling after submandibular gland botulinum neurotoxin A injections in children with neurodevelopmental disabilities","volume":"62","author":"van Hulst","year":"2020","journal-title":"Dev. Med. Child Neurol."},{"issue":"9","key":"10.1016\/j.ejpn.2025.09.001_bib10","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/dmcn.14898","article-title":"The challenges of posterior drooling in children with cerebral palsy","volume":"63","author":"Reddihough","year":"2021","journal-title":"Dev. Med. Child Neurol."},{"issue":"8","key":"10.1016\/j.ejpn.2025.09.001_bib12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/000992289803700805","article-title":"Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy","volume":"37","author":"Bachrach","year":"1998","journal-title":"Clin. Pediatr."},{"issue":"9","key":"10.1016\/j.ejpn.2025.09.001_bib13","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/archpedi.1996.02170340046009","article-title":"Glycopyrrolate treatment of chronic drooling","volume":"150","author":"Blasco","year":"1996","journal-title":"Arch. Pediatr. Adolesc. Med."},{"issue":"12","key":"10.1016\/j.ejpn.2025.09.001_bib14","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/archpedi.154.12.1214","article-title":"Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study","volume":"154","author":"Mier","year":"2000","journal-title":"Arch. Pediatr. Adolesc. Med."},{"issue":"4","key":"10.1016\/j.ejpn.2025.09.001_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/archdischild-2017-313763","article-title":"Drooling reduction intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability","volume":"103","author":"Parr","year":"2018","journal-title":"Arch. Dis. Child."},{"issue":"3","key":"10.1016\/j.ejpn.2025.09.001_bib16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/dmcn.14350","article-title":"Anticholinergic medications for reducing drooling in children with developmental disability","volume":"62","author":"Reid","year":"2020","journal-title":"Dev. Med. Child Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2025.09.001_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1440-1754.1997.tb00991.x","article-title":"Preliminary study of glycopyrrolate in the management of drooling","volume":"33","author":"Stern","year":"1997","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/j.ejpn.2025.09.001_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/TCRM.S27362","article-title":"Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions","volume":"8","author":"Zeller","year":"2012","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.ejpn.2025.09.001_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/TCRM.S26893","article-title":"Randomized phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions","volume":"8","author":"Zeller","year":"2012","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.ejpn.2025.09.001_bib20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jpeds.2021.06.062","article-title":"Real-world evidence for assessing treatment effectiveness and safety in pediatric populations","volume":"238","author":"Horton","year":"2021","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.ejpn.2025.09.001_bib21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/10543406.2022.2152834","article-title":"Real world data (RWD) in pediatrics","volume":"33","author":"Lasky","year":"2023","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.ejpn.2025.09.001_bib22","series-title":"EPAR - Product Information","year":"2016"},{"issue":"2","key":"10.1016\/j.ejpn.2025.09.001_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02412423","article-title":"Three treatment approaches and clinical factors in the reduction of drooling","volume":"3","author":"Thomas-Stonell","year":"1988","journal-title":"Dysphagia"},{"issue":"5","key":"10.1016\/j.ejpn.2025.09.001_bib24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10882-017-9553-1","article-title":"Outpatient treatment based on self-management strategies for chronic drooling in two children","volume":"29","author":"de Bruijn","year":"2017","journal-title":"J. Dev. Phys. Disabil."},{"issue":"9","key":"10.1016\/j.ejpn.2025.09.001_bib25","first-page":"2229","article-title":"Preventability and severity assessment in reporting adverse drug reactions","volume":"49","author":"Hartwig","year":"1992","journal-title":"Am. J. Hosp. Pharm."},{"issue":"3","key":"10.1016\/j.ejpn.2025.09.001_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/qhc.0100135","article-title":"The satisfaction with information about medicines scale (SIMS): a new measurement tool for audit and research","volume":"10","author":"Horne","year":"2001","journal-title":"Quality in Health Care"},{"key":"10.1016\/j.ejpn.2025.09.001_bib27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7525-2-12","article-title":"Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease","volume":"2","author":"Atkinson","year":"2004","journal-title":"Health Qual. Life Outcome"},{"issue":"11","key":"10.1016\/j.ejpn.2025.09.001_bib28","doi-asserted-by":"crossref","first-page":"e1195","DOI":"10.1212\/WNL.0000000000007081","article-title":"Randomized controlled trial comparing botulinum vs surgery for drooling in neurodisabilities","volume":"92","author":"Bekkers","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2025.09.001_bib29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijporl.2019.04.036","article-title":"Unsuccessful submandibular duct surgery for anterior drooling: surgical failure or parotid gland salivation?","volume":"123","author":"Delsing","year":"2019","journal-title":"Int. J. Pediatric Otorhinolaryngoly"},{"key":"10.1016\/j.ejpn.2025.09.001_bib30","series-title":"Cerebral Palsy in Under 25s: Assessment and Management","year":"2017"},{"issue":"2","key":"10.1016\/j.ejpn.2025.09.001_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5498\/wjp.v4.i2.30","article-title":"What's in a name? Compliance, adherence and concordance in chronic psychiatric disorders","volume":"4","author":"Chakrabarti","year":"2014","journal-title":"World J. Psychiatr."},{"key":"10.1016\/j.ejpn.2025.09.001_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/PPA.S17822","article-title":"Compliance, concordance, and patient-centered care","volume":"5","author":"Lawn","year":"2011","journal-title":"Patient Prefer. Adherence"},{"issue":"1","key":"10.1016\/j.ejpn.2025.09.001_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11096-018-0756-z","article-title":"The treatment-related experiences of parents, children and young people with regular prescribed medication","volume":"41","author":"Aston","year":"2019","journal-title":"Int. J. Clinical Pharmacol."},{"issue":"1","key":"10.1016\/j.ejpn.2025.09.001_bib34","first-page":"6","article-title":"Pharmacologic management of sialorrhea in neonatal and pediatric patients","volume":"29","author":"Bradford","year":"2024","journal-title":"J. Pediatr. Pharmacol. Therapeut."},{"issue":"7","key":"10.1016\/j.ejpn.2025.09.001_bib35","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/dmcn.15841","article-title":"Glycopyrronium 320 \u03bcg\/mL in children and adolescents with severe sialorrhoea and neurodisabilities: a randomized, double-blind, placebo-controlled trial","volume":"66","author":"Fayoux","year":"2024","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2025.09.001_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejpn.2024.05.004","article-title":"The when, why, and how of using glycopyrronium to diminish drooling in children with neurodevelopmental disabilities: implications for clinical practice","volume":"51","author":"Orri\u00ebns","year":"2024","journal-title":"Eur. J. Paediatr. Neurol."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379825001357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379825001357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T23:27:34Z","timestamp":1767310054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379825001357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":35,"alternative-id":["S1090379825001357"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2025.09.001","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ins and outs of glycopyrronium treatment for paediatric drooling: exploring the treatment journey using real-world data","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2025.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.","name":"copyright","label":"Copyright"}]}}